Close

Roth Capital Positive on Cytokinetics (CYTK) Following 'Milestone' ALS Study Enrollment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/26/2024

1. META
2. GOOGL
3. CMG
4. MSFT
5. LRCX
6. IBM
7. SPY
8. INTC
9. SNAP
10. BA


Go back to Roth Capital Positive on Cytokinetics (CYTK) Following 'Milestone' ALS Study Enrollment

Cytokinetics (CYTK) Announces Completion of VITALITY-ALS Patient Enrollment

August 17, 2016 7:33 AM EDT

Cytokinetics, Inc. (Nasdaq: CYTK) announced the completion of patient enrollment in VITALITY-ALS (Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices after... More